MICHAEL MEADOR: Open Payments
NPI 1033424189 · WILLOW PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 36 payments from 10 companies in 2025. Trend: 2023 $527 · 2024 $577 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $162 |
| Lilly USA, LLC | 11 | $157 |
| Novo Nordisk Inc | 10 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Exact Sciences Corporation | 1 | $21 |
| Amgen Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MOUNJARO, FARXIGA, JARDIANCE, BREZTRI, INSPIRE, Rybelsus, Ozempic, Wegovy.
Industry payments across TX — which companies pay providers there.
